Drug profile · INN
depemokimab-ulaa
EXDENSUR
depemokimab-ulaa (EXDENSUR) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — depemokimab-ulaa
- US status
- approved
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
depemokimab-ulaa (EXDENSUR) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
INN depemokimab-ulaa
Brand EXDENSUR
Formulation INJECTION
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is depemokimab-ulaa?
depemokimab-ulaa (EXDENSUR) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for depemokimab-ulaa?
EXDENSUR is a marketed brand name for depemokimab-ulaa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of depemokimab-ulaa?
depemokimab-ulaa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.